Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent
Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
Reuters
Thu, 07/25/24 - 11:26 am
Sanofi
Dupixent
earnings
Sanofi to more than double its workforce at Hyderabad site with $437M expansion: reports
Fierce Pharma
Wed, 07/17/24 - 12:11 pm
Sanofi
India
Hyderabad
Flu vaccine makers CSL Seqirus, Sanofi and GSK kick off initial shipments ahead of upcoming season
Fierce Pharma
Thu, 07/11/24 - 11:35 am
flu vaccines
CSL Seqirus
Sanofi
GSK
vaccines
Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD
Fierce Pharma
Wed, 07/3/24 - 11:26 am
Sanofi
Regeneron
Europe
COPD
Dupixent
Sanofi eyes investment of up to $1.6 bln in Germany, Handelsblatt says
Reuters
Mon, 07/1/24 - 11:11 am
Sanofi
insulin
drug manufacturing
Germany
Sanofi reports findings from Phase II relapsing MS treatment trial
Clinical Trials Arena
Mon, 07/1/24 - 11:00 am
Sanofi
frexalimab
relapsing multiple sclerosis
MS
clinical trials
Sanofi reports positive data from Phase III EoE treatment trial
Clinical Trials Arena
Thu, 06/27/24 - 11:29 am
Sanofi
Dupixent
eosinophilic esophagitis
clinical trials
AI-focused Formation secures Sanofi-backed $372M series D to license more drugs
Fierce Biotech
Wed, 06/26/24 - 10:11 am
Formation Bio
funding
artificial intelligence
Sanofi
Sanofi reports data from Phase II demyelinating polyneuropathy trial
Clinical Trials Arena
Wed, 06/26/24 - 09:55 am
Sanofi
riliprubart
clinical trials
demyelinating polyneuropathy
Sanofi Seeks Initial Offers for Its $20 Billion Consumer Arm
Yahoo/Bloomberg
Tue, 06/25/24 - 09:13 pm
Sanofi
M&A
consumer health
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
Reuters
Fri, 06/21/24 - 11:47 am
GSK
Pfizer
Sanofi
Delaware
Zantac
legal
PhRMA
Prostate Drugs May Find New Use in Reducing Risk of Dementia: Study
BioSpace
Thu, 06/20/24 - 11:18 am
dementia
dementia with Lewy bodies
α-blockers
Abbott Labs
Hytrin
Pfizer
Cardura
Uroxatral
Sanofi
Sanofi taps Belharra for immune drug research
BioPharma Dive
Tue, 06/18/24 - 11:42 am
Sanofi
Belharra Therapeutics
small molecule drugs
Dupixent repeats as top pharma ad brand, rankings largely unchanged in May
Medical Marketing and Media
Tue, 06/11/24 - 10:49 pm
pharma advertising
DTC advertising
Dupixent
Regeneron
Sanofi
Dupixent nears EU approval for COPD, as FDA delays
Pharmaphorum
Fri, 05/31/24 - 10:49 am
Sanofi
Regeneron
Dupixent
COPD
EMA
Europe
FDA
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena
Thu, 05/23/24 - 10:58 am
Sanofi
clinical trials
rilzabrutinib
asthma
Sanofi, Bristol Myers on the hook for $916M in do-over of Plavix marketing case in Hawaii
Fierce Pharma
Wed, 05/22/24 - 10:26 pm
Bristol Myers Squibb
Sanofi
Plavix
legal
pharma marketing
Hawaii
Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
Reuters
Tue, 05/21/24 - 07:13 pm
Sanofi
drug development
artificial intelligence
OpenAI
Formation Bio
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Amgen
AstraZeneca
COPD
Sanofi
Regeneron
Tezspire
Dupixent
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »